Single-Agent Treatment in High-Risk Metastatic Breast CanceringentaconnectOnkologie Germering Karger
FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia. Oncologist. 2008 Feb;13(2):167-74.Demko S, Summers J, Keegan P, Pazdur R. FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia. ...
[15] A problem often detected in previous epidemiological analyses was that co-morbidities and competing causes of mortality diminished the actual impact of chemotherapy; therefore, this aspect needs to be carefully examined before making generalisations regarding treatment approaches.[16] Usually, the ...
Drs Tannir, Tykodi, and Ornstein debate whether single-agent TKI therapies still have a place in advanced clear cell RCC treatment, especially for favorable-risk patients.This is a modal window. This video is either unavailable or not supported in this browser...
Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Ad... More effective therapies are needed in the specific treatment of severe inflammatory acne vulgaris.To demonstrate superior efficacy of adapalene...
Treatment of head and neck cancer with intra-arterial cytotoxic drugs and radiotherapy Advanced head and neck cancer thought to be incurable by irradiation or surgery alone or in combination was treated by intra-arterial chemotherapy and radi... R Sealy,P Helman - 《Cancer》 被引量: 354发表: ...
Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis of bone. 来自 NCBI 喜欢 0 阅读量: 23 作者:R Haupt,A Comelli,C Rosanda,M Sessarego,BD Bernardi 摘要: The first case of secondary leukemia (FAB M3 microgranular variant) after single-agent ...
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-1... Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: ...
(1) Reliable evidence supports the use of thiazide diuretics (chlortalidone or hydrochlorothiazide) as first-line treatment for uncomplicated arterial hypertension. (2) When patients fail to reach blood pressure targets with well-conducted treatment with thiazide diuretics, or this treatment is poorly ...
Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma. Leukemia. 2005; 19(1):156-159.Fenk R, Hoyer B, Steidl U, Kondakci M, Graef T, Heuk R, et al. Single-agent thalidomide for treatment of first relapse follow- ing ...